| Tatyana Petrosova, MD | |
|
555 N New Ballas Rd Ste 210, Saint Louis, MO 63141-6844 | |
| (314) 993-4949 | |
| (314) 993-4945 |
| Full Name | Tatyana Petrosova |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 36 Years |
| Location | 555 N New Ballas Rd Ste 210, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023089562 | NPI | - | NPPES |
| 207235706 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 036107203 (Illinois) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | 2002007108 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake St Louis At Home | Lake saint louis, MO | Dialysis facility |
| Lake St Louis Dialysis | Lake saint louis, MO | Dialysis facility |
| Hazelwood Dialysis | Hazelwood, MO | Dialysis facility |
| St Peters Dialysis | Saint peters, MO | Dialysis facility |
| Ssm St Joseph Hospital West | Lake saint louis, MO | Hospital |
| Ssm Depaul Health Center | Bridgeton, MO | Hospital |
| Ssm St Joseph Health Center | Saint charles, MO | Hospital |
| Progress West Hospital | O fallon, MO | Hospital |
| Barnes-jewish St Peters Hospital | Saint peters, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tatyana Petrosova Md Pc | 4082757034 | 2 |
News Archive
A new $1.8 million grant from the Department of Defense will allow North Carolina State University researchers to work with the Walter Reed Institute of Research to further test the effectiveness of molecules that have shown great promise in combating antibiotic-resistant infections.
Premier Purchasing Partners, LP, today announced that contracts have been awarded to suppliers in its new radiation oncology portfolio.
Novo Nordisk announced today that the U.S. Food and Drug Administration has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making the hemophilia A or B with inhibitors treatment available in 1, 2, 5 and 8 mg vials. The 8 mg vial allows a rapid initiation and administration of this medication for those patients who need a larger dose. In addition, FDA has also approved the extension of shelf life for all vial sizes from 24 months to 36 months at room temperature (at or below 77 degrees Fahrenheit).
Scientists from the Queensland Institute of Medical Research have made a breakthrough in the treatment of throat cancer. The researchers have developed a therapy that uses a patient's blood to grow special white blood cells that recognize and fight infected cancer cells. The results of this study have been published in the journal Cancer Research.
› Verified 2 days ago
| Entity Name | Tatyana Petrosova Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700026515 PECOS PAC ID: 4082757034 Enrollment ID: O20100130000071 |
News Archive
A new $1.8 million grant from the Department of Defense will allow North Carolina State University researchers to work with the Walter Reed Institute of Research to further test the effectiveness of molecules that have shown great promise in combating antibiotic-resistant infections.
Premier Purchasing Partners, LP, today announced that contracts have been awarded to suppliers in its new radiation oncology portfolio.
Novo Nordisk announced today that the U.S. Food and Drug Administration has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making the hemophilia A or B with inhibitors treatment available in 1, 2, 5 and 8 mg vials. The 8 mg vial allows a rapid initiation and administration of this medication for those patients who need a larger dose. In addition, FDA has also approved the extension of shelf life for all vial sizes from 24 months to 36 months at room temperature (at or below 77 degrees Fahrenheit).
Scientists from the Queensland Institute of Medical Research have made a breakthrough in the treatment of throat cancer. The researchers have developed a therapy that uses a patient's blood to grow special white blood cells that recognize and fight infected cancer cells. The results of this study have been published in the journal Cancer Research.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tatyana Petrosova, MD Po Box 653, Chesterfield, MO 63006-0653 Ph: (314) 993-4949 | Tatyana Petrosova, MD 555 N New Ballas Rd Ste 210, Saint Louis, MO 63141-6844 Ph: (314) 993-4949 |
News Archive
A new $1.8 million grant from the Department of Defense will allow North Carolina State University researchers to work with the Walter Reed Institute of Research to further test the effectiveness of molecules that have shown great promise in combating antibiotic-resistant infections.
Premier Purchasing Partners, LP, today announced that contracts have been awarded to suppliers in its new radiation oncology portfolio.
Novo Nordisk announced today that the U.S. Food and Drug Administration has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making the hemophilia A or B with inhibitors treatment available in 1, 2, 5 and 8 mg vials. The 8 mg vial allows a rapid initiation and administration of this medication for those patients who need a larger dose. In addition, FDA has also approved the extension of shelf life for all vial sizes from 24 months to 36 months at room temperature (at or below 77 degrees Fahrenheit).
Scientists from the Queensland Institute of Medical Research have made a breakthrough in the treatment of throat cancer. The researchers have developed a therapy that uses a patient's blood to grow special white blood cells that recognize and fight infected cancer cells. The results of this study have been published in the journal Cancer Research.
› Verified 2 days ago
Dr. Isik Turker, MD Nephrology Medicare: Medicare Enrolled Practice Location: 4921 Parkview Pl, Div Im Cardiology, Ste 8b, Saint Louis, MO 63110 Phone: 314-362-1291 Fax: 314-362-4278 | |
Conor Mccartney, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 915 N Grand Blvd, Saint Louis, MO 63106 Phone: 314-652-4100 | |
Dr. Faris Adam Bakeer, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Rehan Rais, M.D. M.B.,B.S. Nephrology Medicare: Medicare Enrolled Practice Location: 660 S Euclid Ave, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Nathan Farkas, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1 Barnes Jew Hosp Plz, Saint Louis, MO 63110 Phone: 314-362-1930 | |
Dr. Nicole Foley, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Soumojit Ghosh, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3660 Vista Ave, Saint Louis, MO 63110 Phone: 314-977-6100 Fax: 314-977-6164 |